COVID-19患者的促红细胞生成素治疗 - Suppr

Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19.

作者信息

Fishbane Steven, Hirsch Jamie S

机构信息

Division of Kidney Diseases and Hypertension, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Health, Great Neck, NY.

出版信息

Am J Kidney Dis. 2020 Sep;76(3):303-305. doi: 10.1053/j.ajkd.2020.05.002. Epub 2020 May 29.

DOI:10.1053/j.ajkd.2020.05.002

PMID:32479920

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7256552/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c722/7256552/0f6059aeca5f/gr1_lrg.jpg

相似文献

Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19.

Am J Kidney Dis. 2020 Sep;76(3):303-305. doi: 10.1053/j.ajkd.2020.05.002. Epub 2020 May 29.

EPO in Patients With COVID-19: More Than an Erythropoietic Hormone.

Am J Kidney Dis. 2020 Sep;76(3):441. doi: 10.1053/j.ajkd.2020.06.002. Epub 2020 Jun 10.

SGLT-2 inhibitors for COVID-19 - A miracle waiting to happen or just another beat around the bush?

Prim Care Diabetes. 2020 Oct;14(5):564-565. doi: 10.1016/j.pcd.2020.05.013. Epub 2020 May 28.

Hydroxychloroquine pharmacokinetic in COVID-19 critically ill patients: an observational cohort study.

Intensive Care Med. 2020 Sep;46(9):1772-1773. doi: 10.1007/s00134-020-06142-y. Epub 2020 Jun 8.

Are statins safe in patients with COVID-19?

J Clin Lipidol. 2020 Jul-Aug;14(4):396-397. doi: 10.1016/j.jacl.2020.06.009. Epub 2020 Jun 22.

COVID-19 update: Covid-19-associated coagulopathy.

J Thromb Thrombolysis. 2020 Jul;50(1):54-67. doi: 10.1007/s11239-020-02134-3.

Revisiting the Protein C Pathway: An Opportunity for Adjunctive Intervention in COVID-19?

Anesth Analg. 2020 Sep;131(3):690-693. doi: 10.1213/ANE.0000000000005059.

Lessons from the Italian COVID-19 frontline.

Minerva Med. 2020 Aug;111(4):303-305. doi: 10.23736/S0026-4806.20.06664-1.

Use of convalescent plasma in COVID-19 patients in China.

Transfus Clin Biol. 2020 Aug;27(3):168-169. doi: 10.1016/j.tracli.2020.05.001. Epub 2020 May 16.

COVID-19 and Acute Kidney Injury.

Nephrol Nurs J. 2020 Sep-Oct;47(5):481-482.

引用本文的文献

Impact of SARS-CoV-2 Infection on Erythropoietin Resistance Index in Hemodialysis Patients.

Geriatrics (Basel). 2025 Feb 24;10(2):33. doi: 10.3390/geriatrics10020033.

Research on the global trends of COVID-19 associated acute kidney injury: a bibliometric analysis.

Ren Fail. 2024 Dec;46(1):2338484. doi: 10.1080/0886022X.2024.2338484. Epub 2024 Jun 4.

The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study.

Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231218216. doi: 10.1177/10760296231218216.

Using inflammatory indices for assessing malnutrition among COVID-19 patients: A single-center retrospective study.

J Infect Public Health. 2022 Dec;15(12):1472-1476. doi: 10.1016/j.jiph.2022.11.006. Epub 2022 Nov 11.

COVID-19: A nephrologists' perspective.

J Postgrad Med. 2022 Oct-Dec;68(4):187-193. doi: 10.4103/jpgm.jpgm_470_22.

Presentation and Outcomes of Patients With End-Stage Kidney Disease Hospitalized With COVID-19 at a Tertiary Center in Riyadh, Kingdom of Saudi Arabia.

Cureus. 2022 Mar 28;14(3):e23575. doi: 10.7759/cureus.23575. eCollection 2022 Mar.

Increased 1-year mortality in haemodialysis patients with COVID-19: a prospective, observational study.

Clin Kidney J. 2021 Dec 20;15(3):432-441. doi: 10.1093/ckj/sfab248. eCollection 2022 Mar.

Challenging patient phenotypes in the management of anaemia of chronic kidney disease.

Int J Clin Pract. 2021 Nov;75(11):e14681. doi: 10.1111/ijcp.14681. Epub 2021 Aug 12.

Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era.

Front Oncol. 2021 Jul 8;11:697908. doi: 10.3389/fonc.2021.697908. eCollection 2021.

The oxygen dissociation curve of blood in COVID-19.

Am J Physiol Lung Cell Mol Physiol. 2021 Aug 1;321(2):L349-L357. doi: 10.1152/ajplung.00079.2021. Epub 2021 May 12.

本文引用的文献

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.

Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4.

Acute Pulmonary Embolism in Patients with COVID-19 at CT Angiography and Relationship to d-Dimer Levels.

Radiology. 2020 Sep;296(3):E189-E191. doi: 10.1148/radiol.2020201561. Epub 2020 Apr 23.

Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.

N Engl J Med. 2019 Sep 12;381(11):1011-1022. doi: 10.1056/NEJMoa1901713. Epub 2019 Jul 24.

Anemia of inflammation.

Blood. 2019 Jan 3;133(1):40-50. doi: 10.1182/blood-2018-06-856500. Epub 2018 Nov 6.

Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*.

Crit Care Med. 2015 Feb;43(2):401-10. doi: 10.1097/CCM.0000000000000713.

Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease.

Ann Intern Med. 2010 Jul 6;153(1):23-33. doi: 10.7326/0003-4819-153-1-201007060-00252. Epub 2010 Jun 24.

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

N Engl J Med. 2009 Nov 19;361(21):2019-32. doi: 10.1056/NEJMoa0907845. Epub 2009 Oct 30.

Causes and consequences of inflammation on anemia management in hemodialysis patients.

Hemodial Int. 2009 Apr;13(2):222-34. doi: 10.1111/j.1542-4758.2009.00352.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19.

Am J Kidney Dis. 2020 Sep;76(3):303-305. doi: 10.1053/j.ajkd.2020.05.002. Epub 2020 May 29.

EPO in Patients With COVID-19: More Than an Erythropoietic Hormone.

Am J Kidney Dis. 2020 Sep;76(3):441. doi: 10.1053/j.ajkd.2020.06.002. Epub 2020 Jun 10.

SGLT-2 inhibitors for COVID-19 - A miracle waiting to happen or just another beat around the bush?

Prim Care Diabetes. 2020 Oct;14(5):564-565. doi: 10.1016/j.pcd.2020.05.013. Epub 2020 May 28.

Hydroxychloroquine pharmacokinetic in COVID-19 critically ill patients: an observational cohort study.

Intensive Care Med. 2020 Sep;46(9):1772-1773. doi: 10.1007/s00134-020-06142-y. Epub 2020 Jun 8.

Are statins safe in patients with COVID-19?

J Clin Lipidol. 2020 Jul-Aug;14(4):396-397. doi: 10.1016/j.jacl.2020.06.009. Epub 2020 Jun 22.

COVID-19 update: Covid-19-associated coagulopathy.

J Thromb Thrombolysis. 2020 Jul;50(1):54-67. doi: 10.1007/s11239-020-02134-3.

Revisiting the Protein C Pathway: An Opportunity for Adjunctive Intervention in COVID-19?

Anesth Analg. 2020 Sep;131(3):690-693. doi: 10.1213/ANE.0000000000005059.

Lessons from the Italian COVID-19 frontline.

Minerva Med. 2020 Aug;111(4):303-305. doi: 10.23736/S0026-4806.20.06664-1.

Use of convalescent plasma in COVID-19 patients in China.

Transfus Clin Biol. 2020 Aug;27(3):168-169. doi: 10.1016/j.tracli.2020.05.001. Epub 2020 May 16.

COVID-19 and Acute Kidney Injury.

Nephrol Nurs J. 2020 Sep-Oct;47(5):481-482.

引用本文的文献

Impact of SARS-CoV-2 Infection on Erythropoietin Resistance Index in Hemodialysis Patients.

Geriatrics (Basel). 2025 Feb 24;10(2):33. doi: 10.3390/geriatrics10020033.

Research on the global trends of COVID-19 associated acute kidney injury: a bibliometric analysis.

Ren Fail. 2024 Dec;46(1):2338484. doi: 10.1080/0886022X.2024.2338484. Epub 2024 Jun 4.

The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study.

Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231218216. doi: 10.1177/10760296231218216.

Using inflammatory indices for assessing malnutrition among COVID-19 patients: A single-center retrospective study.

J Infect Public Health. 2022 Dec;15(12):1472-1476. doi: 10.1016/j.jiph.2022.11.006. Epub 2022 Nov 11.

COVID-19: A nephrologists' perspective.

J Postgrad Med. 2022 Oct-Dec;68(4):187-193. doi: 10.4103/jpgm.jpgm_470_22.

Presentation and Outcomes of Patients With End-Stage Kidney Disease Hospitalized With COVID-19 at a Tertiary Center in Riyadh, Kingdom of Saudi Arabia.

Cureus. 2022 Mar 28;14(3):e23575. doi: 10.7759/cureus.23575. eCollection 2022 Mar.

Increased 1-year mortality in haemodialysis patients with COVID-19: a prospective, observational study.

Clin Kidney J. 2021 Dec 20;15(3):432-441. doi: 10.1093/ckj/sfab248. eCollection 2022 Mar.

Challenging patient phenotypes in the management of anaemia of chronic kidney disease.

Int J Clin Pract. 2021 Nov;75(11):e14681. doi: 10.1111/ijcp.14681. Epub 2021 Aug 12.

Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era.

Front Oncol. 2021 Jul 8;11:697908. doi: 10.3389/fonc.2021.697908. eCollection 2021.

The oxygen dissociation curve of blood in COVID-19.

Am J Physiol Lung Cell Mol Physiol. 2021 Aug 1;321(2):L349-L357. doi: 10.1152/ajplung.00079.2021. Epub 2021 May 12.

本文引用的文献

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.

Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4.

Acute Pulmonary Embolism in Patients with COVID-19 at CT Angiography and Relationship to d-Dimer Levels.

Radiology. 2020 Sep;296(3):E189-E191. doi: 10.1148/radiol.2020201561. Epub 2020 Apr 23.

Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.

N Engl J Med. 2019 Sep 12;381(11):1011-1022. doi: 10.1056/NEJMoa1901713. Epub 2019 Jul 24.

Anemia of inflammation.

Blood. 2019 Jan 3;133(1):40-50. doi: 10.1182/blood-2018-06-856500. Epub 2018 Nov 6.

Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*.

Crit Care Med. 2015 Feb;43(2):401-10. doi: 10.1097/CCM.0000000000000713.

Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease.

Ann Intern Med. 2010 Jul 6;153(1):23-33. doi: 10.7326/0003-4819-153-1-201007060-00252. Epub 2010 Jun 24.

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

N Engl J Med. 2009 Nov 19;361(21):2019-32. doi: 10.1056/NEJMoa0907845. Epub 2009 Oct 30.

Causes and consequences of inflammation on anemia management in hemodialysis patients.

Hemodial Int. 2009 Apr;13(2):222-34. doi: 10.1111/j.1542-4758.2009.00352.x.

Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献